Identification of Key Blood Molecular Markers for Immunotherapy
NCT00507702 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 191
Last updated 2019-04-18
Summary
To identify unique blood markers in cancer patients so that we can identify patients with evidence of pre-existing immunity who may be a responder to immunotherapy.
Conditions
- Squamous Cell Carcinoma
- Adenocarcinoma
- Neoplasms
Interventions
- PROCEDURE
-
phlebotomy
Standard of care
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Jeffrey A. Norton · Stanford University
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-07-06
- Primary Completion
- 2015-02-25
- Completion
- 2015-02-25
Countries
- United States
Study Locations
More Related Trials
-
Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors
NCT03662204 ·Status: COMPLETED
-
A Biomarker Screening Protocol for Participants With Solid Tumors
NCT05891197 ·Status: TERMINATED
-
Molecular Analysis of Thoracic Malignancies
NCT01385722 ·Status: ENROLLING_BY_INVITATION
-
Identification of Marker of Primary or Acquired Resistance to Anti Tumorous Treatment
NCT02105168 ·Status: UNKNOWN ·Phase: NA
-
Identification of Secreted Markers for Tumor Hypoxia in Patients With Head and Neck or Lung Cancers
NCT00568490 ·Status: RECRUITING
-
Biomarkers in Tumor Tissue Samples From Patients With Peripheral T-cell Lymphoma or Natural Killer Cell Neoplasms
NCT01390597 ·Status: COMPLETED
-
Immunophenotyping in Metastatic Kidney Cancer Patients Receiving Ablative Therapy
NCT05112627 ·Status: COMPLETED
-
Clinical Validation of a Microfluidic Device for Isolation and Molecular Characterization of Circulating Tumor Cells
NCT01022723 ·Status: UNKNOWN
-
Biomarker Expression in Samples From Young Patients With Anaplastic Large Cell Lymphoma
NCT01366170 ·Status: COMPLETED
-
Gene Expression in Samples From Patients With T-Cell Acute Lymphoblastic Leukemia
NCT01520246 ·Status: COMPLETED
-
Biomarkers in Blood and Tissue Samples From Patients With Newly Diagnosed Neuroblastoma
NCT01387724 ·Status: COMPLETED
-
Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Hematologic Malignancies
NCT03727009 ·Status: TERMINATED
-
Canadian Initiative to Measure, Predict and Assess Cancer Treatment Outcomes in Patients Treated With Immuno-Oncotherapeutics
NCT06630273 ·Status: NOT_YET_RECRUITING
-
Integrated Molecular Profiling in Advanced Cancers Trial
NCT01505400 ·Status: ACTIVE_NOT_RECRUITING
-
Collection of Blood From Patients With Cancer
NCT00034216 ·Status: RECRUITING
-
Collection and Storage of Tissue and Blood Samples From Patients With Cancer
NCT02474160 ·Status: RECRUITING
-
Collection of Biospecimen & Clinical Information in Patients w/ Gastrointestinal Cancers
NCT01031056 ·Status: WITHDRAWN
-
Exploring Cancer-Associated Thromboembolism Prognosis Biomarkers and Polymorphisms
NCT06065592 ·Status: RECRUITING ·Phase: PHASE1
-
Survey and Blood Sample Collection for Patients With Lung Cancer Who Never Smoked Cigarettes
NCT00745160 ·Status: COMPLETED
-
UWCCC Molecular Tumor Board Registry
NCT03023202 ·Status: RECRUITING
-
A Systems Approach to Immunotherapy Biomarker Identification Within the Postoperative Wound-Healing Microenvironment in Patients With Gastroesophageal Cancer
NCT05338060 ·Status: COMPLETED
-
Blood Biomarker Signature in Glioma
NCT03698201 ·Status: TERMINATED
-
Immunobiology of Cancer
NCT00767533 ·Status: TERMINATED
-
Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Melanoma
NCT03727087 ·Status: TERMINATED
-
Molecular Markers and Genetic Markers in Patients Undergoing Radiation Therapy for Cancer
NCT00899808 ·Status: WITHDRAWN